mRNA-1189

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-1189, covering 2025-05-15 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age [Phase 1]

See pricing